Literature DB >> 10024881

Allosteric regulation of even-skipped repression activity by phosphorylation.

C Li1, J L Manley.   

Abstract

The Drosophila homeodomain protein Even-skipped (Eve) is a well characterized transcriptional repressor. Here, we show that Eve's ability to function in vitro is negatively regulated by phosphorylation. DNA-binding activity was unaffected by phosphorylation, but phosphorylated Eve was unable to interact with the TATA-binding protein (TBP), a known target for repression. Unexpectedly, phosphorylation of the Eve N terminus, which is dispensable for repression and TBP binding, was necessary and sufficient to inactivate Eve. LiCl, which specifically inhibits glycogen synthase kinase-3 (GSK-3), reduced Eve phosphorylation in nuclear extract and blocked inhibition of repression. In addition, Eve was phosphorylated and inactivated by purified GSK-3 beta plus casein kinase II. Our results suggest a novel mechanism of transcriptional control involving phosphorylation-induced allosteric interference with a repressive protein-protein interaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10024881     DOI: 10.1016/s1097-2765(00)80176-8

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  10 in total

1.  Evolutionary conserved mechanism of transcriptional repression by even-skipped.

Authors:  L M McKay; B Carpenter; S G Roberts
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  Role for Hes1-induced phosphorylation in Groucho-mediated transcriptional repression.

Authors:  Hugh N Nuthall; Junaid Husain; Keith W McLarren; Stefano Stifani
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Drawing lines in the sand: even skipped et al. and parasegment boundaries.

Authors:  James B Jaynes; Miki Fujioka
Journal:  Dev Biol       Date:  2004-05-15       Impact factor: 3.582

4.  The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes.

Authors:  K Kuwahara; Y Saito; E Ogawa; N Takahashi; Y Nakagawa; Y Naruse; M Harada; I Hamanaka; T Izumi; Y Miyamoto; I Kishimoto; R Kawakami; M Nakanishi; N Mori; K Nakao
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Functional phosphorylation sites in the C-terminal region of the multivalent multifunctional transcriptional factor CTCF.

Authors:  E M Klenova; I V Chernukhin; A El-Kady; R E Lee; E M Pugacheva; D I Loukinov; G H Goodwin; D Delgado; G N Filippova; J León; H C Morse; P E Neiman; V V Lobanenkov
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  Serine/threonine phosphorylation of calmodulin modulates its interaction with the binding domains of target enzymes.

Authors:  E Leclerc; C Corti; H Schmid; S Vetter; P James; E Carafoli
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

7.  NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.

Authors:  Xiang Li; Bin Guan; Sam Maghami; Charles J Bieberich
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1.

Authors:  Edwin Chen; Xiaoyong Huang; Yanzhen Zheng; You-Jun Li; Alden Chesney; Yaacov Ben-David; Eric Yang; Margaret R Hough
Journal:  Mol Cancer       Date:  2010-09-16       Impact factor: 27.401

9.  The repressor activity of Even-skipped is highly conserved, and is sufficient to activate engrailed and to regulate both the spacing and stability of parasegment boundaries.

Authors:  Miki Fujioka; Galina L Yusibova; Nipam H Patel; Susan J Brown; James B Jaynes
Journal:  Development       Date:  2002-10       Impact factor: 6.868

10.  CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding.

Authors:  Abdenour Soufi; Peter Noy; Malcolm Buckle; Anyaporn Sawasdichai; Kevin Gaston; Padma-Sheela Jayaraman
Journal:  Nucleic Acids Res       Date:  2009-03-25       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.